GENMAB A/S
Develops innovative antibody therapeutics for cancer and other serious diseases.
GMAB | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- TOLDBODGADE 33, 0 1253 COPENHAGEN K
- Website:
- https://www.genmab.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genmab A/S is an international biotechnology company focused on the creation and development of innovative and differentiated antibody therapeutics. The company leverages its proprietary antibody science and pioneering technologies to develop next-generation treatments aimed at improving the lives of patients with cancer and other serious diseases. Genmab's core mission is to transform disease treatment through a patient-driven, collaborative approach to creating novel antibody-based products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GENMAB A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENMAB A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENMAB A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
